Clinical Trial Update: Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigates whether vitamin D3 (cholecalciferol) supplementation affects treatment outcomes in depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Region Syddanmark | Conditions: Depression | Phase 4 | Status: UNKNOWN